Vertex Pharmaceuticals VRTX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.34B— | $3.95B— | —— | —— | —— | ||
| $217.3M+7.5% | $209.8M+1.3% | $200.6M-8.7% | $199.8M-4.2% | $202.1M+3.1% | ||
| $686.2M+2.0% | $685.9M-1.8% | $696.1M-5.8% | $685.8M0.0% | $672.7M+3.4% | ||
| $4.24B+233% | $3.63B+235% | $3.01B+229% | $1.65B+274% | -$3.18B-181% | ||
| $530.3M+96.4% | $437.6M+47.0% | $380.8M+44.7% | $346.7M+46.8% | $270M+19.1% | ||
| -$1.32B+21.8% | -$945.4M+74.9% | -$1.48B+61.4% | -$1.71B+52.6% | -$1.69B+51.0% | ||
| $1.93B+31.0% | $2.02B+71.4% | $2.31B+154% | $1.54B+115% | $1.47B+246% | ||
| -$2.12B-16.6% | -$2.26B-51.3% | -$2.58B-111% | -$1.81B-80.7% | -$1.82B-183% | ||
| $853.7M— | $549.8M— | -$266.1M— | —— | —— | ||
| $3.71B+208% | $3.19B+207% | $2.65B+202% | $1.31B+211% | -$3.44B-193% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vertex Pharmaceuticals generate?
- Vertex Pharmaceuticals (VRTX) generated $4.2B in operating cash flow over the trailing twelve months.
- What is Vertex Pharmaceuticals's free cash flow?
- After $530.3M of capital expenditures, Vertex Pharmaceuticals's free cash flow was $3.7B over the trailing twelve months, up 207.9% year over year.
- Where does Vertex Pharmaceuticals's cash flow data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
